SynthesisFrontiers in medicine2026

Anti-type 2 monoclonal antibody therapy for eosinophilic COPD beyond triple therapy: a systematic review and meta-analysis with strict eosinophil inclusion criteria.

Jialing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.